Covaxin
- Jun- 2021 -30 JuneDH NEWS
Covaxin effective against Alpha & Delta Covid Variants: Top US Health Institute
According to the US National Institute of Health, India’s Covaxin, developed by Bharat Biotech in partnership with the Indian Council…
Read More » - 19 JuneDH Latest News
Woman in Bihar gets two different vaccine shots in 5 minutes
Patna: Within a span of five minutes, a woman in Bihar was given shots of Covishield and Covaxin Covid-19 vaccines.…
Read More » - 15 JuneDH Latest News
20% of 18+ population received at least 1st dose, says govt
New Delhi: The government’s medical bulletin, on Monday, said that about 1.37 million people in the 18-45 age group in…
Read More » - 15 JuneDelhi
Covaxin clinical trials on 6-12-year-olds, AIIMS to start screening
New Delhi: On Tuesday, the All India Institute of Medical Sciences (AIIMS), New Delhi will start screening children in the…
Read More » - 12 JuneDH Latest News
BB publishes studies on the efficacy of Covid vaccine
New Delhi: In a span of just twelve months, Bharat Biotech has published as many as nine research studies on…
Read More » - 8 JuneDH Latest News
Union government announced revised vaccine rates for private hospitals
New Delhi: The Union government has announced the revised rates of Covid vaccines for private hospitals in the country. The…
Read More » - 8 JuneDH Latest News
Central govt places fresh orders for Covishield and Covaxin
New Delhi: On Tuesday, the government stated that it has placed fresh orders for 25 crores more doses of Covishield…
Read More » - 8 JuneDH Latest News
New Covid variant detected in India, says NIV
New Delhi: Pune’s National Institute of Virology has discovered a new Covid-19 variant — B.1.1.28.2 — through genome sequencing of…
Read More » - 7 JuneDelhi
Screening of children for Covaxin trials commences in the country
New Delhi: India has started the screening of children aged between 2 and 18 for the trial of the Covid-19…
Read More » - 7 JuneDH NEWS
Which Covid vaccine is more effective: Covaxin or Covishield? : A study
New Delhi: Based on a study conducted by Coronavirus Vaccine-induced Antibody Titre (COVAT) has found that seropositivity rates and the median…
Read More » - 3 JuneDH Latest News
Covid vaccine: Trial for Covaxin in children started in the country
Patna: The Covid vaccine Covaxin, developed in India, has started clinical trials in children. The experiment is being conducted at…
Read More » - May- 2021 -29 MayDH Latest News
Covid vaccine: Covaxin production to reach 10 cr doses per month by September, says Health Minister
New Delhi: The Ministry of Health and Family Welfare (MoHFW) on Friday said that in the midst of an acute…
Read More » - 28 MayDH Latest News
India’s Covid-19 vaccination exercise will be completed by December 2021: Union Minister Prakash Javadekar
New Delhi: The government has announced that it will complete the administration of the Covid 19 vaccine in the country…
Read More » - 23 MayDH Latest News
India to push to include Covaxin in the ‘Emergency Use List’ of WHO
New Delhi: The union government will make it sure that the Indian made vaccine, Covaxin to will be included in…
Read More » - 20 MayDH Latest News
EDITORIAL; “Vaccination is like an arranged marriage.First, u r not ready, then u don’t like any, then u don’t get any”
Recently many browsers would have associated with the national game of, chase the vaccine. They would have equated the experience…
Read More » - 19 MayDH Latest News
Covid vaccine for kids: Govt says Covaxin trials to begin in 10-12 days
New Delhi: The government said on Tuesday trials on Covaxin’s efficacy against coronavirus on children between 2-18 years of age…
Read More » - 16 MayDH Latest News
National Institute of Virology reveals about effectiveness of COVAXIN
New Delhi: A new study has revealed the effectiveness of COVAXIN against the muted strains of Coronavirus. The new research…
Read More » - 15 MayDH Latest News
Covid-19 surge: Centre to supply 1.9 crore Covid vaccine to States and UTs
New Delhi: In the midst of the calls of vaccine shortage in States and UTs, the Union government has said…
Read More » - 15 MayDH Latest News
Covid vaccination for 18-45-year-old starts on Monday: CM Pinarayi Vijayan
Thiruvananthapuram: Vaccination of 18 to 45-year-olds in the state will begin from Monday. Chief Minister Pinarayi Vijayan said in a…
Read More » - 13 MayDH Latest News
India to vaccinate all citizens by year-end, 216 crores vaccine doses to be available
New Delhi: Dr VK Paul, Member (Health), NITI Aayog, said that 216 crores of Covid vaccine will be manufactured in…
Read More » - 13 MayDH Latest News
Bharat Biotech says ‘disheartening’; while 2 CM’s complain of slow vaccine production
HYDERABAD: Bharat Biotech has termed the complaints as “disheartening” after Delhi chief minister Arvind Kejriwal and Andhra Pradesh CM YS…
Read More » - 12 MayDH Latest News
Covid vaccination: Covaxin gets approval for phase 2/3 trials on 2-18 year-olds
New Delhi: On Tuesday, an expert committee recommended Bharat Biotech’s COVID-19 vaccine Covaxin for phase II/III clinical trial on those…
Read More » - 5 MayDH Latest News
Madhya Pradesh: Covid vaccination for people of age group 18-44 starts today
Bhopal: A senior official said that vaccinations against COVID-19 for people in the 18-44 age group will begin in Madhya…
Read More » - 4 MayDH Latest News
Efficiency check of Corona vaccine, Indian Covid-19 variant sample send to Uk
A request from the United Kingdom, samples of the double-mutant Indian variant of the coronavirus, suspected to be fuelling the…
Read More » - Apr- 2021 -30 AprilDH Latest News
A farmer’s son from Tamil Nadu is the ‘ man behind’ India’s Covaxin
The success story of Dr Krishna Ella, the man behind India’s Covid-19 vaccine is a motivating one. Dr Krishna Ella,…
Read More » - 29 AprilDH Latest News
Bharat Biotech: Covaxin’s price reduced to Rs 400 per dose
On Thursday, Bharat Biotech declared it will charge state governments ?400 for a dose of Covaxin, instead of ?600, as…
Read More » - 28 AprilDH Latest News
Home grown vaccine found to neutralize 617 Indian variants.
According to White House chief medical adviser and America’s top pandemic expert Dr Anthony Fauci said, India’s home-grown COVID-19 vaccine,…
Read More » - 25 AprilDH NEWS
Coronavirus vaccination: Registration needed for 18-45 age group
New Delhi: To get coronavirus vaccination appointments and online registrations of citizens in the age group of 18 to 44…
Read More » - 25 AprilDH Latest News
Covishield & Covaxin: Things you need to know about the vaccines
Everyone above 18 years, from May 1, will be regarded eligible for getting a vaccination against Covid-19 only through advanced…
Read More » - 25 AprilDH Latest News
Covid-19 vaccination program – Phase 3: Covaxin prices announced
The developer and manufacturer of Covid-19 vaccine Covaxin, Bharat Biotech, today announced the prices to be charged from state governments…
Read More » - 22 AprilDH Latest News
Coronavirus: 0.04% people infected after receiving Covaxin second dose; 0.03% after Covishield
On Wednesday, the Indian government said 0.03 per cent of people tested positive for coronavirus after taking the second dose…
Read More » - 21 AprilDH Latest News
Covaxin effective against Double Mutant Strain In India
Made-in-India COVID-19 vaccine, Covaxin, neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, the…
Read More » - 21 AprilDH Latest News
Covid-19 vaccine: Bharat Biotech increases Covaxin production to 700 million doses
Bharat Biotech has decided to increase the manufacturing capacity of its COVID-19 vaccine, Covaxin, to 700 million doses per annum,…
Read More » - 19 AprilDH Latest News
Covid-19 vaccines shortage, India to fund capacity boost at Serum Institute
A government source with knowledge of the matter told Reuters that India is set to receive the Serum Institute of…
Read More » - 17 AprilDH Latest News
Coronavirus: SII CEO appeals to U.S. to lift the embargo on export of raw material for vaccine
Serum Institute of India CEO Adar Poonawalla Friday requested US President Joe Biden to lift the restriction on the export…
Read More »